Global Indocyanine Green Market Growth 2023-2029
Indocyanine green (ICG) a cyanine dye used in medical diagnostics to determine cardiac output, hepatic function, and liver blood flow, and for ophthalmic angiography. It is a sterile, lyophilized green powder with a peak spectral absorption at 800 nm. These infrared frequencies penetrate retinal layers, allowing ICG angiography to image deeper patterns of circulation than fluorescein angiography.
LPI (LP Information)' newest research report, the “Indocyanine Green Industry Forecast” looks at past sales and reviews total world Indocyanine Green sales in 2022, providing a comprehensive analysis by region and market sector of projected Indocyanine Green sales for 2023 through 2029. With Indocyanine Green sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Indocyanine Green industry.
This Insight Report provides a comprehensive analysis of the global Indocyanine Green landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Indocyanine Green portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Indocyanine Green market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Indocyanine Green and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Indocyanine Green.
The global Indocyanine Green market size is projected to grow from US$ 48 million in 2022 to US$ 67 million in 2029; it is expected to grow at a CAGR of 67 from 2023 to 2029.
Europe is the largest market with about 52% market share. USA and China are follower, accounting for about 33% market share.
The key players are Akorn, PULSION Medical Systems AG, Diagnostic Green, SERB, Daiichi Sankyo Company, Santen Pharmaceutical Co., Ltd., Aurolab, Yichuang, Eisai etc. Top 3 companies occupied about 60% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of Indocyanine Green market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Type I
Type II
Segmentation by application
Ophthalmology
Neurosurgery
Liver Diseases
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Akorn
PULSION Medical Systems AG
Diagnostic Green
SERB
Daiichi Sankyo Company
Santen Pharmaceutical Co., Ltd.
Aurolab
Yichuang
Eisai
Key Questions Addressed in this Report
What is the 10-year outlook for the global Indocyanine Green market?
What factors are driving Indocyanine Green market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Indocyanine Green market opportunities vary by end market size?
How does Indocyanine Green break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook